CVS Health Corp. shares CVS are up a fraction in premarket trading on Wednesday, after the company announced it would reiterate its financial goals for 2023 at an investor’s meeting. CVS continues to estimate an adjusted profit of $8.50-$8.70 per share in 2023, as compared to FactSet’s estimate of $8.62. CVS stated in a filing that it continues to expect medical costs to remain consistent with its pricing expectations. “We continue to expect slightly over 50% of the full-year earning in the second half 2023. Third quarter earnings will be modestly higher than those of fourth quarter.”